Topiramate add-on therapy for drug-resistant focal epilepsy-Reference-Cited by-同舟云学术

Topiramate add-on therapy for drug-resistant focal epilepsy

Published:2019-10-23 Issue:10 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bresnahan Rebecca¹,Hounsome Juliet²,Jette Nathalie³,Hutton Jane L⁴,Marson Anthony G¹⁵⁶

Affiliation:

1. Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Lower Lane Liverpool UK L9 7LJ

2. University of Liverpool; Liverpool Reviews and Implementation Group; Sherrington Building Ashton Street Liverpool UK L69 3GE

3. Icahn School of Medicine at Mount Sinai; Neurology; One Gustave L. Levey Place Box 1137 New York New York USA 10029

4. University of Warwick; Department of Statistics; Coventry UK CV4 7AL

5. The Walton Centre NHS Foundation Trust; Liverpool UK

6. Liverpool Health Partners; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001417.pub4/epdf/full

Reference73 articles.

1. Double-blind, placebo-controlled trial of 800 mg/day topiramate as add-on therapy in patients with refractory partial epilepsy;Ben-Menachem;Epilepsia,1995

2. Topiramate add-on treatment in patients with intractable partial epilepsy: a multicenter study;Ben-Menachem;Epilepsia,1993

3. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures;Ben-Menachem;Epilepsia,1996

4. Double-blind, placebo-controlled trial of 400 mg/day topiramate as add-on therapy in patients with refractory partial epilepsy;Martinez-Lage;Epilepsia,1995

5. Topiramate as add-on therapy in refractory partial epilepsy;Ostergard;Epilepsia,1992

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New possibilities of overcoming pharmacoresistance in epilepsy;Medical alphabet;2024-01-19

2. Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling;Annals of Clinical and Translational Neurology;2023-12-07

3. Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy;CNS Drugs;2023-06

4. Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study;PLOS ONE;2022-12-30

5. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies;CNS Drugs;2022-10